Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating DNA, Circulating RNA, Circulating Tumor Cells

Jeff Stoll's Biography

Jeff Stoll, Vice President, Life Sciences, Ernst & Young LLP

Prior to EY, Jeff was a Vice President at Scientia Advisors where he developed and lead the TA and Product Strategy practice, a global practice focused on product and TA strategy, corporate strategy, and deal diligence. Prior to joining Scientia Advisors, Jeff was the therapeutic leader for inflammatory diseases and CNS at IMS Health where he focused on commercial strategy, due diligence and therapeutic area assessment for several top 15 global pharmaceutical clients. Prior to joining IMS Health, Jeff was a Assistant Professor at the University of Florida (Shands Hospital) where he was a member of the medical review boards for heart, lung, liver and kidney transplant services.

Jeff Stoll Image

Breakfast Briefing: The State of M&A and Partnerships in Global Companion Diagnostics

Tuesday, 24 March 2015 at 08:00

Add to Calendar ▼2015-03-24 08:00:002015-03-24 09:00:00Europe/LondonBreakfast Briefing: The State of MandA and Partnerships in Global Companion

Presenters will highlight the current state of M&A and partnerships in CDx amongst all stakeholders from a financial and a commercial perspective.  Based upon the experience at EY in M&A and partnership diligence and commercial strategy development and their EY Precision Medicine ™ programs, they will outline areas where strides have been made to improve successful co-development and launch of Rx and CDx programs, and outline areas where different industry values/priorities and technology advances continue to challenge the overall potential of these partnerships.

Add to Calendar ▼2015-03-23 00:00:002015-03-24 00:00:00Europe/LondonCirculating DNA, Circulating RNA, Circulating Tumor